Blood Diagnostics and OurCrowd

Selected news for the healthcare topic - Blood Diagnostics, and the capital firm - OurCrowd. We have a small number of shared news items for this connection to-date.

Please provide a valid email address.
Blood Diagnostics Shares Healthcare News With (link):
Healthcare Topics
Companies
Capital Firms
People

Selected Headlines

Date Headline (link) Source Relevant Snippet
8/5/2020 Sight Diagnostics raises $71M Series D for its blood analyzer TechCrunch ... D round with participation from Koch Disruptive Technologies , Longliv Ventures (which led its Series C round ) and crowd-funding platform OurCrowd . With this, the company has now raised a total of $124 million, though the ... the surface of the ability of AI to help with blood diagnostics,” said Pollak. “Specifically now, there’s so much value around COVID in decentralizing diagnostics and blood tests. Think keeping people — COVID-negative or -positive ...
8/5/2020 Tabletop blood tester Sight Diagnostics raises $71M to expand commercial reach | FierceBiotech FierceBiotech ... finger-prick’s worth of blood. The Tel Aviv-based company’s series D round was backed by Koch Disruptive Technologies and OurCrowd, plus a follow-on investment from CK Hutchison’s Longliv Ventures. The proceeds bring Sight’s ... only is the company bringing truly innovative solutions to the blood diagnostics industry, it is also driving a vision to decentralize information and increase consumer access in healthcare markets across the world.” RELATED: Tabletop blood ...
8/5/2020 Sight Diagnostics hauls in $71M Series D for point-of-care blood analysis MobiHealthNews ... vision-based finger-prick analysis device, announced today $71 million in Series D funding. Koch Disruptive Technologies, Longliv Ventures and OurCrowd all participated in the round. According to the company, this newest raise brings its ... key drivers of that growth. Sight's approach of AI-based blood diagnostics runs parallel to that of 1Drop Diagnostics. This startup, which raised $4.25 million in late 2018 , measures biomarkers from a single drop of ...
8/5/2020 Sight Diagnostics hauls in $71M Series D for fingerprick blood analysis MobiHealthNews ... vision-based finger-prick analysis device, announced today $71 million in Series D funding. Koch Disruptive Technologies, Longliv Ventures and OurCrowd all participated in the round. According to the company, this newest raise brings its ... key drivers of that growth. Sight's approach of AI-based blood diagnostics runs parallel to that of 1Drop Diagnostics. This startup, which raised $4.25 million in late 2018 , measures biomarkers from a single drop of ...